Gail Connor Roche

The rate of palliative care in patients with multiple sclerosis to have died in US hospitals increased from 7.7% to 58.8% over 10 years

Influenza vaccinations among patients with diabetes rose by 20% when they were notified about scheduling their flu shot, according to a new study.

Health care providers managing patients with MS should remain cognizant of the link between unhealthy lifestyle behaviors and depression risks.

Hispanic adults in the US who are infected with human immunodeficiency virus face a greater risk of cancers caused by human papillomavirus (HPV) than Hispanics in the general public.

Stigma may cause undiagnosed individuals with HIV to go unidentified and fail to get quality care and treatment.

A majority of patients with hepatitis C experience disorders outside of the liver that are related to the virus.

CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.

Thus far there is no intervention that clearly reduces the risk of HCV infection from a mother to her child.

Sofosbuvir/velpatasvir is the first direct acting antiviral therapy registered for use against all 6 genotypes of hepatitis C.

Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.

HIV-positive patients need to maintain healthy body weight, quit smoking, eat well, exercise regularly and treat hypertension, diabetes and dyslipidemia.

Direct-acting antivirals drugs show similar cure rates in co-infected patients as high as mono-infected patients.

Nine other countries are on track to eliminate the hepatitis C virus by 2030.

Patients with hepatitis C who achieved sustained virologic response with a direct-acting antiviral maintained health improvements that enhanced their long-term quality of life.

An aspirin a day may reduce their risk of hepatocellular carcinoma in patients with hepatitis B virus.

Heart transplant patients with hepatitis C often cannot not tolerate interferon-based regimens due to cardiac toxicity and other heart-related problems.

Researchers evaluate potential reasons why HIV some drug combinations are more effective in certain patients.

Women with the hepatitis C virus have fewer live births and face a higher risk of miscarriage, infertility, gestational diabetes and pre-eclampsia.

Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals.

Sofosbuvir may help improve the kidney function of some patients with hepatitis C virus.

The risk of irregular and rapid heartbeat increased in type 1 diabetic patients who had renal complications and poor glycemic control.

Determining how hepatitis C progresses is important when considering therapies and the associated costs for different patient groups.

The risk of developing liver cancer is similar with direct-acting antiviral drugs or interferon therapy for hepatitis C virus.

Baby boomer hepatitis C virus screening rates spiked when a prompt in their electronic health records reminded a primary care provider to recommend testing.

Gestational diabetes mellitus can cause complications for both mothers and their babies.

New generation of antiviral drugs cause significant reduction in the risk for the most common type of adult liver cancer in patients with HCV.

Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.

Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.

Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.

The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.